HAPPE Spine, a cultivate(MD) portfolio company with a proprietary biomaterial and manufacturing platform for creating bone-integrating implants, announces that the INTEGRATE®-C Interbody Fusion System has been implanted in more than 1,000 patients, demonstrating clinical adoption of the HAPPE® platform across more than 30 surgeon users and 40 facilities nationwide.
HAPPE Spine Reaches 1,000 Patients Read More »
We’re proud to share that HAPPE Spine, a portfolio company of cultivate(MD), has been selected for the MedTech Innovator 2025 Accelerator Cohort, an honor reserved for the top 4% of nearly 1,500 global applicants. This recognition reflects both the strength of HAPPE’s mission and the game-changing potential of their breakthrough spinal implant technology. MedTech Innovator
HAPPE Spine Selected for MedTech Innovator 2025 Accelerator Cohort Read More »
We’re excited to announce that Dr. Ryan Roeder from HAPPE Spine will be delivering a scientific presentation on “Next Generation PEEK Interbody Fusion Devices: Scientific Foundations and Clinical Outcomes” Thursday, August 15, 2024 at 7 PM CT. This pre-meeting webinar is part of the upcoming North American Spine Society (NASS) conference, and it’s an incredible
Dr. Ryan Roeder Presenting at NASS Webinar Read More »
We are thrilled to announce that the INTEGRATE®-C from HAPPE Spine has been recognized among the Best New Spine Technologies of 2023 by Orthopaedics This Week!
INTEGRATE®-C Named to Best New Spine Technologies of 2023 Read More »
Grand Rapids, Mich., August 14, 2023—HAPPE Spine announces that the first clinical case with the INTEGRATE®-C Interbody Fusion System was completed by co-inventor and neurosurgeon Dr. Stephen Smith, MD, at the Beacon Health System – Memorial Hospital in South Bend, Indiana. Dr. Smith said, “The Integrate-C handled extremely well and went right to work. The
HAPPE Spine Announces First Clinical Use of the INTEGRATE®-C Interbody Fusion System Read More »
Grand Rapids, Mich., May 8, 2023 — HAPPE Spine, a medical device company focused on bringing innovative materials to orthopaedic implants, announces that the company’s INTEGRATE-C™ Interbody Fusion System has received 510k clearance from the FDA.
HAPPE Spine Announces FDA Clearance for the INTEGRATE-C™ Interbody Fusion System Read More »
